Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study

We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55–74 years (the Edinburgh Artery Study). 272 fatal and non‐fatal c...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of haematology Vol. 96; no. 1; pp. 168 - 173
Main Authors Lowe, G. D. O., Lee, A. J., Rumley, A., Price, J. F., Fowkes, F. G. R.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.01.1997
Blackwell
Subjects
Online AccessGet full text
ISSN0007-1048
1365-2141
DOI10.1046/j.1365-2141.1997.8532481.x

Cover

Abstract We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55–74 years (the Edinburgh Artery Study). 272 fatal and non‐fatal cardiovascular events occurred during 5 years of follow‐up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit‐corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low‐density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested.
AbstractList We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55–74 years (the Edinburgh Artery Study). 272 fatal and non‐fatal cardiovascular events occurred during 5 years of follow‐up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit‐corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low‐density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested.
We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55–74 years (the Edinburgh Artery Study). 272 fatal and non‐fatal cardiovascular events occurred during 5 years of follow‐up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit‐corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low‐density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested.
We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55-74 years (the Edinburgh Artery Study). 272 fatal and non-fatal cardiovascular events occurred during 5 years of follow-up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit-corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low-density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested.We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55-74 years (the Edinburgh Artery Study). 272 fatal and non-fatal cardiovascular events occurred during 5 years of follow-up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit-corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low-density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested.
We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a prospective study of a random population sample of 1592 men and women aged 55-74 years (the Edinburgh Artery Study). 272 fatal and non-fatal cardiovascular events occurred during 5 years of follow-up (cumulative incidence 17.1%). Age and sex adjusted mean levels of blood viscosity (3.70 v 3.55 mPa.s), haematocrit (46.2 v 45.7%), haematocrit-corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s) and fibrinogen (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did not. The relationships of these rheological variables to cardiovascular events were at least as strong as those of conventional risk factors (smoking habit, diastolic blood pressure, and low-density lipoprotein cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and haematocrit remained significant for stroke, but not for total events; whereas the associations of plasma viscosity and fibrinogen remained significant for total events and for stroke. These findings suggest that increased blood viscosity may be one plausible biological mechanism through which increases in haematocrit and fibrinogen may promote ischaemic heart disease and stroke. Randomized controlled trials of viscosity reduction in the prevention of cardiovascular events (e.g. by lowering high levels of haematocrit or plasma fibrinogen) are suggested.
Author Rumley, A.
Price, J. F.
Lowe, G. D. O.
Lee, A. J.
Fowkes, F. G. R.
Author_xml – sequence: 1
  givenname: G. D. O.
  surname: Lowe
  fullname: Lowe, G. D. O.
– sequence: 2
  givenname: A. J.
  surname: Lee
  fullname: Lee, A. J.
– sequence: 3
  givenname: A.
  surname: Rumley
  fullname: Rumley, A.
– sequence: 4
  givenname: J. F.
  surname: Price
  fullname: Price, J. F.
– sequence: 5
  givenname: F. G. R.
  surname: Fowkes
  fullname: Fowkes, F. G. R.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2543511$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9012704$$D View this record in MEDLINE/PubMed
BookMark eNqVkc1O3DAUha0KRAfoI1Syqopdgm9i52cWFTOIliIQC-jacmyn4yETg-0M5O1JNNEsWLUryzrfOfa59xgdtLbVCH0DEgOh2fk6hjRjUQIUYijLPC5YmtAC4rdPaLaXDtCMEJJHg6X4jI69XxMCKWFwhI5KAklO6AzdLRtrFd4aL603oceiVdgZ_4RtjaVwytit8LJrhMN6q9vg5zisNL5Spq0693eFFy5o1-OH0Kn-FB3WovH6y3SeoD8_rx4vr6Pb-1-_Lxe3kWSQpVEOpWSKiqpOCsaEkrSWQmpdQaIlKCUrkVFRZ7kuslImRA2fpkpRyphURJbpCTrb5T47-9JpH_hmKKCbRrTadp7nRQGMliP4dQK7aqMVf3ZmI1zPp_6D_n3Sh5KiqZ1opfF7LGE0ZQADNt9h0lnvna73BBA-roSv-Th3Ps6djyvh00r422C--GCWJohgbBucMM2_RfzYRbyaRvf_8Thf3lwPl_QdJ5KmxA
CODEN BJHEAL
CitedBy_id crossref_primary_10_1111_eci_14127
crossref_primary_10_15406_ijcam_2016_04_00107
crossref_primary_10_1021_acs_analchem_1c05208
crossref_primary_10_1108_HFF_11_2022_0629
crossref_primary_10_1161_01_CIR_97_15_1467
crossref_primary_10_1080_09513590903015486
crossref_primary_10_1097_00001721_200010000_00004
crossref_primary_10_1159_000350377
crossref_primary_10_1371_journal_pgen_1003110
crossref_primary_10_3390_jfb13040205
crossref_primary_10_1007_s00431_005_1725_9
crossref_primary_10_1590_S0004_27302006000100016
crossref_primary_10_1177_1358863X9700200207
crossref_primary_10_1016_j_clinbiochem_2012_10_015
crossref_primary_10_1177_147323001003800611
crossref_primary_10_1007_s10557_012_6402_4
crossref_primary_10_1186_s12889_024_20988_7
crossref_primary_10_1016_j_ijcard_2005_11_104
crossref_primary_10_1186_1471_2458_14_474
crossref_primary_10_1016_j_jeem_2023_102846
crossref_primary_10_17816_KMJ2021_156
crossref_primary_10_1097_00041433_199910000_00008
crossref_primary_10_4274_kvbulten_galenos_2025_85057
crossref_primary_10_1212_01_wnl_0000183057_96792_a8
crossref_primary_10_1097_MPH_0b013e31804bdb12
crossref_primary_10_1179_135100009X392458
crossref_primary_10_1007_s10067_019_04603_4
crossref_primary_10_1016_j_sna_2020_112176
crossref_primary_10_1161_HYPERTENSIONAHA_119_12780
crossref_primary_10_1016_j_jmmm_2016_11_088
crossref_primary_10_1016_j_jstrokecerebrovasdis_2016_07_031
crossref_primary_10_1111_j_1751_9004_2009_00205_x
crossref_primary_10_1088_1742_6596_1073_4_042046
crossref_primary_10_23921_amp_2018v2i3_15965
crossref_primary_10_3390_ijms241914952
crossref_primary_10_3390_polym15092039
crossref_primary_10_1007_s11434_012_5165_4
crossref_primary_10_32596_ejcm_galenos_2022_2021_11_059
crossref_primary_10_1177_2047487316672004
crossref_primary_10_2217_nmt_2019_0010
crossref_primary_10_1093_ageing_afp227
crossref_primary_10_1080_10407782_2017_1293976
crossref_primary_10_1016_j_ahj_2008_08_011
crossref_primary_10_1055_s_0043_1775965
crossref_primary_10_1111_ijcp_14878
crossref_primary_10_1016_j_jstrokecerebrovasdis_2013_08_004
crossref_primary_10_1161_01_ATV_18_5_768
crossref_primary_10_3233_CH_151954
crossref_primary_10_1109_ACCESS_2019_2963355
crossref_primary_10_3390_sports7050123
crossref_primary_10_1016_j_jns_2018_11_030
crossref_primary_10_30565_medalanya_828026
crossref_primary_10_1016_j_repc_2019_04_008
crossref_primary_10_1007_s12573_011_0037_0
crossref_primary_10_1016_j_atherosclerosis_2021_09_015
crossref_primary_10_1111_j_1440_1746_2006_04266_x
crossref_primary_10_1088_2631_8695_abfd47
crossref_primary_10_1115_1_4025609
crossref_primary_10_1016_j_thromres_2018_11_027
crossref_primary_10_1007_s00592_017_1004_z
crossref_primary_10_1039_D4SD00188E
crossref_primary_10_1161_HYPERTENSIONAHA_112_193565
crossref_primary_10_3390_ijms20174088
crossref_primary_10_1111_j_1742_1241_2004_00143_x
crossref_primary_10_1115_1_4043036
crossref_primary_10_1016_j_ces_2011_12_015
crossref_primary_10_5551_jat_43968
crossref_primary_10_1055_s_0043_1775858
crossref_primary_10_3389_fphar_2020_00213
crossref_primary_10_1161_01_CIR_99_16_2192
crossref_primary_10_1016_j_metabol_2005_01_018
crossref_primary_10_1002_mrm_25015
crossref_primary_10_1016_j_bbi_2016_10_017
crossref_primary_10_1007_s10557_020_07067_w
crossref_primary_10_1309_4LCN_JMPG_5U71_UWQB
crossref_primary_10_3389_fmed_2023_1152747
crossref_primary_10_1016_S0140_6736_05_71810_9
crossref_primary_10_1016_j_jmmm_2015_08_094
crossref_primary_10_1371_journal_pone_0294095
crossref_primary_10_1046_j_1365_2141_1999_01158_x
crossref_primary_10_1152_ajpheart_00330_2001
crossref_primary_10_1161_hc4701_099580
crossref_primary_10_1136_bmjopen_2016_011720
crossref_primary_10_1111_j_1469_8986_2007_00536_x
crossref_primary_10_1210_jc_2010_0266
crossref_primary_10_1016_j_hfc_2008_03_005
crossref_primary_10_3389_fneur_2023_1320773
crossref_primary_10_1093_synbio_ysab023
crossref_primary_10_35440_hutfd_843952
crossref_primary_10_1002_ehf2_13513
crossref_primary_10_1080_19338240903392640
crossref_primary_10_1186_s12883_024_03812_y
crossref_primary_10_1016_j_biopsycho_2007_09_005
crossref_primary_10_2478_jce_2020_0002
crossref_primary_10_1097_PCC_0000000000001709
crossref_primary_10_1371_journal_pone_0267747
crossref_primary_10_3390_healthcare10040665
crossref_primary_10_7759_cureus_64211
crossref_primary_10_1016_j_cca_2014_07_041
crossref_primary_10_1161_01_STR_30_4_841
crossref_primary_10_3233_CH_190701
crossref_primary_10_1080_09537104_2019_1678115
crossref_primary_10_1006_jmbi_1997_1392
crossref_primary_10_1007_s10557_018_6815_9
crossref_primary_10_2217_fnl_11_1
crossref_primary_10_1063_5_0111653
crossref_primary_10_1109_TUFFC_2005_1397353
crossref_primary_10_1111_j_1442_2042_2006_01734_x
crossref_primary_10_3389_fstro_2025_1517343
crossref_primary_10_1007_s11883_000_0106_0
crossref_primary_10_1177_1076029618775511
crossref_primary_10_1002_jca_21770
crossref_primary_10_1046_j_1365_2141_2000_02026_x
crossref_primary_10_3233_CH_141892
crossref_primary_10_1136_jnnp_2016_314704
crossref_primary_10_24287_1726_1708_2022_21_3_136_141
crossref_primary_10_1177_0972063416637703
crossref_primary_10_1177_03000605231169435
crossref_primary_10_1152_ajpheart_00438_2012
crossref_primary_10_1210_clinem_dgad651
crossref_primary_10_1039_C6TB01827K
crossref_primary_10_3109_02699052_2013_823562
crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106687
crossref_primary_10_1016_S0015_0282_03_01173_7
crossref_primary_10_1038_aja_2011_102
crossref_primary_10_1038_s41598_021_98472_0
crossref_primary_10_1016_j_sna_2022_113456
crossref_primary_10_1038_s41598_021_00263_0
crossref_primary_10_1177_1753944716642676
crossref_primary_10_3390_ani13233694
crossref_primary_10_1038_s41598_019_42594_z
crossref_primary_10_1016_j_sna_2023_114497
crossref_primary_10_1016_S1889_1837_03_71352_X
crossref_primary_10_1007_s10557_010_6239_7
crossref_primary_10_1111_j_1525_1594_2010_01078_x
crossref_primary_10_1002_uog_14782
crossref_primary_10_3390_app131910684
crossref_primary_10_1364_BOE_10_003974
crossref_primary_10_1089_acm_2011_0820
crossref_primary_10_1016_S0021_9150_01_00656_6
crossref_primary_10_1161_01_STR_0000181754_38408_4c
crossref_primary_10_1002_ajh_26038
crossref_primary_10_1016_j_heliyon_2020_e04792
crossref_primary_10_1136_bmjopen_2020_046682
crossref_primary_10_3390_membranes12020217
crossref_primary_10_1021_ac2032386
crossref_primary_10_1097_00001721_200112000_00006
crossref_primary_10_1097_01_CCM_0000182827_50341_18
crossref_primary_10_1016_j_repce_2019_04_001
crossref_primary_10_1021_acs_analchem_9b00624
crossref_primary_10_3233_CH_211343
crossref_primary_10_1161_JAHA_123_034162
crossref_primary_10_2169_internalmedicine_55_5311
crossref_primary_10_1137_24M1632425
crossref_primary_10_18663_tjcl_1184730
crossref_primary_10_1016_j_jep_2009_01_017
crossref_primary_10_1111_j_1523_1755_2004_00484_x
crossref_primary_10_1161_CIRCULATIONAHA_105_557132
crossref_primary_10_1111_j_1748_1716_2009_02037_x
crossref_primary_10_3390_bioengineering11121298
crossref_primary_10_2217_clp_12_65
crossref_primary_10_3389_fphys_2020_616145
crossref_primary_10_1007_s10544_019_0426_5
crossref_primary_10_2217_bmm_2019_0246
crossref_primary_10_7759_cureus_41657
crossref_primary_10_1016_j_ejvs_2024_09_036
crossref_primary_10_1111_j_1365_2362_2005_01437_x
crossref_primary_10_2217_bmm_2019_0483
crossref_primary_10_1289_ehp_5646
crossref_primary_10_1111_j_1469_8986_2006_00485_x
crossref_primary_10_1080_10739680802229316
crossref_primary_10_2217_bmm_16_10
crossref_primary_10_1016_j_saa_2019_04_028
crossref_primary_10_1016_S0167_4943_00_00063_7
crossref_primary_10_1007_s00380_019_01486_y
crossref_primary_10_1007_s00216_017_0218_9
crossref_primary_10_1016_j_envint_2018_04_047
crossref_primary_10_1021_ac9016659
crossref_primary_10_1253_circj_CJ_22_0512
crossref_primary_10_1021_acs_analchem_6b03347
crossref_primary_10_1038_s41598_018_25317_8
crossref_primary_10_1067_mhj_2002_119758
crossref_primary_10_1007_s00484_013_0641_3
crossref_primary_10_1016_j_heliyon_2024_e27954
crossref_primary_10_1136_bmjopen_2014_005067
crossref_primary_10_4103_0028_3886_284386
crossref_primary_10_1152_japplphysiol_00024_2022
crossref_primary_10_1080_09537100600800529
crossref_primary_10_1177_0267659112463487
crossref_primary_10_1016_j_atherosclerosis_2015_07_014
crossref_primary_10_1159_000494735
crossref_primary_10_1016_j_snb_2016_04_126
crossref_primary_10_2139_ssrn_4090386
crossref_primary_10_1002_jps_24302
crossref_primary_10_1186_s40560_023_00665_4
crossref_primary_10_1115_1_1427042
crossref_primary_10_1007_s10072_021_05666_5
crossref_primary_10_1038_s41598_017_01636_0
crossref_primary_10_1007_s12020_014_0451_3
crossref_primary_10_3389_fnut_2025_1530908
crossref_primary_10_1007_s11332_018_0486_6
crossref_primary_10_1016_j_dsx_2012_05_009
crossref_primary_10_3390_biomedicines13010015
crossref_primary_10_1159_000083845
crossref_primary_10_4236_ojpm_2015_54019
crossref_primary_10_1111_iwj_13949
crossref_primary_10_1016_j_jbiomech_2012_01_020
crossref_primary_10_1016_S0049_3848_00_00230_9
crossref_primary_10_1097_00001721_200310000_00001
crossref_primary_10_1111_j_1600_051X_2011_01710_x
crossref_primary_10_1038_s41467_022_28823_6
crossref_primary_10_1111_j_1542_4758_2012_00671_x
crossref_primary_10_1161_hc3501_094232
crossref_primary_10_1016_j_thromres_2024_03_032
crossref_primary_10_1016_j_envpol_2022_119071
crossref_primary_10_20915_2077_1177_2024_20_1_17_30
crossref_primary_10_1007_s00281_011_0290_8
crossref_primary_10_1081_CEH_120005376
crossref_primary_10_1093_qjmed_hch130
crossref_primary_10_1161_CIRCULATIONAHA_105_541433
crossref_primary_10_1097_MD_0000000000005041
crossref_primary_10_2217_bmm_2020_0249
crossref_primary_10_1097_MJT_0000000000000183
crossref_primary_10_1007_s12573_012_0048_5
crossref_primary_10_3390_jcm12247623
crossref_primary_10_1046_j_1423_0410_1998_7510078_x
crossref_primary_10_1016_j_scitotenv_2023_164469
crossref_primary_10_5853_jos_2021_02831
crossref_primary_10_1182_blood_2016_10_746479
crossref_primary_10_1111_j_1538_7836_2007_02481_x
crossref_primary_10_1016_S0021_9150_99_00114_8
crossref_primary_10_1161_HYPERTENSIONAHA_112_191510
crossref_primary_10_1142_S0217979205030190
crossref_primary_10_1016_j_amjcard_2006_01_034
crossref_primary_10_47582_jompac_1424294
crossref_primary_10_3389_fendo_2022_1059473
crossref_primary_10_1088_0960_1317_19_11_115005
crossref_primary_10_1161_01_ATV_17_11_3321
crossref_primary_10_3233_BIR_200240
crossref_primary_10_1016_j_biopsycho_2005_12_004
crossref_primary_10_1103_PhysRevLett_128_094502
crossref_primary_10_1046_j_1526_0968_2002_00366_x
crossref_primary_10_1016_j_bbi_2011_09_009
crossref_primary_10_1177_1753944714553226
crossref_primary_10_1007_s10654_015_0060_3
crossref_primary_10_1016_S1078_5884_97_80290_0
crossref_primary_10_3341_jkos_2015_56_5_753
crossref_primary_10_3390_jcm12010353
crossref_primary_10_3390_pr7060372
crossref_primary_10_1016_j_bpj_2021_05_013
crossref_primary_10_1016_j_thromres_2006_11_009
crossref_primary_10_1016_j_snb_2020_128240
crossref_primary_10_1097_01_hco_0000167722_22453_47
crossref_primary_10_1186_1743_8977_2_2
crossref_primary_10_1007_s00394_016_1170_8
crossref_primary_10_3389_fcell_2021_651776
crossref_primary_10_1053_j_jvca_2019_04_005
crossref_primary_10_1097_JOM_0b013e3182619018
crossref_primary_10_1186_s40981_018_0185_y
crossref_primary_10_3390_ijerph9072312
crossref_primary_10_1007_s11239_023_02881_z
crossref_primary_10_1185_030079903125002289
crossref_primary_10_1111_j_1742_1241_2003_tb10437_x
crossref_primary_10_3390_s22103804
crossref_primary_10_1080_08037050310060508
crossref_primary_10_1016_j_jmbbm_2012_11_008
crossref_primary_10_1016_j_nantod_2022_101517
crossref_primary_10_1016_S0021_9150_98_00144_0
crossref_primary_10_1103_PhysRevE_84_011905
crossref_primary_10_1016_j_thromres_2022_02_016
crossref_primary_10_1373_clinchem_2013_204701
crossref_primary_10_1016_S0895_7061_00_00267_3
crossref_primary_10_1080_00984100290071676
crossref_primary_10_1063_5_0060908
crossref_primary_10_3233_CH_15120
crossref_primary_10_1155_2016_1961327
crossref_primary_10_1097_00005768_200002000_00014
crossref_primary_10_1177_0267659113505637
crossref_primary_10_1007_s40279_017_0715_1
crossref_primary_10_1016_j_diabres_2019_107918
crossref_primary_10_1046_j_1526_0968_2001_00368_x
crossref_primary_10_1016_j_thromres_2010_04_006
crossref_primary_10_1186_s12882_017_0808_y
crossref_primary_10_1097_00001573_199903000_00016
crossref_primary_10_1016_j_clinbiochem_2014_01_021
crossref_primary_10_3390_life13102043
crossref_primary_10_1016_S0021_9150_98_00090_2
crossref_primary_10_1046_j_1365_2141_2003_04475_x
crossref_primary_10_1182_blood_2017_03_745349
crossref_primary_10_1080_20565623_2025_2467607
crossref_primary_10_1063_5_0136309
crossref_primary_10_1177_0267659116661052
crossref_primary_10_1186_s12884_024_07096_5
crossref_primary_10_1016_S0268_9499_99_90084_X
crossref_primary_10_1039_C8NR04398A
crossref_primary_10_1080_03091902_2016_1181216
crossref_primary_10_1039_D0LC00248H
crossref_primary_10_1002_phy2_261
crossref_primary_10_1111_bju_12037
crossref_primary_10_1016_j_mvr_2014_06_013
crossref_primary_10_1016_j_wneu_2022_11_102
crossref_primary_10_1097_MCA_0000000000000661
crossref_primary_10_1378_chest_06_2179
crossref_primary_10_1063_1_3116641
crossref_primary_10_1016_j_atherosclerosis_2011_08_026
crossref_primary_10_3109_02713683_2014_990638
crossref_primary_10_1037_0022_006X_70_3_548
crossref_primary_10_1097_MBC_0000000000001081
crossref_primary_10_1186_s12933_024_02513_7
crossref_primary_10_1177_1753944717745507
crossref_primary_10_1016_j_jtherbio_2020_102622
crossref_primary_10_1016_j_jvs_2014_01_069
crossref_primary_10_1177_147323000903700204
crossref_primary_10_1055_s_0040_1720968
crossref_primary_10_1016_j_clinbiochem_2014_11_006
crossref_primary_10_1111_andr_13283
crossref_primary_10_3233_CH_189413
crossref_primary_10_1017_S0007114510001923
crossref_primary_10_1046_j_1365_2796_2002_01014_x
crossref_primary_10_1016_j_phymed_2008_10_014
crossref_primary_10_1155_2018_5952021
crossref_primary_10_3390_ijms24043784
crossref_primary_10_47429_lmo_2021_11_3_162
crossref_primary_10_1016_j_thromres_2004_08_028
crossref_primary_10_1002_art_22766
crossref_primary_10_1177_1076029609339745
crossref_primary_10_3233_CH_151960
crossref_primary_10_1113_EP088315
crossref_primary_10_1002_ajh_23713
crossref_primary_10_1016_j_thromres_2016_09_019
crossref_primary_10_1159_000431362
crossref_primary_10_1046_j_1365_2141_1998_00626_x
crossref_primary_10_1097_01_mca_0000071769_74379_49
crossref_primary_10_3109_09513590_2011_569783
crossref_primary_10_1046_j_1365_2796_1999_00410_x
crossref_primary_10_3346_jkms_2016_31_12_1943
crossref_primary_10_15406_mojce_2018_04_00115
crossref_primary_10_1007_s42452_019_0737_4
crossref_primary_10_1016_j_wneu_2016_04_110
crossref_primary_10_1126_scirobotics_aav4317
crossref_primary_10_1136_oem_57_1_53
crossref_primary_10_1080_15287390590930171
crossref_primary_10_3233_CH_151974
crossref_primary_10_2174_1871529X21666211214154545
crossref_primary_10_1016_j_brainres_2018_08_023
ContentType Journal Article
Copyright 1997 INIST-CNRS
Copyright_xml – notice: 1997 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1046/j.1365-2141.1997.8532481.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2141
EndPage 173
ExternalDocumentID 9012704
2543511
10_1046_j_1365_2141_1997_8532481_x
BJH853
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom
Scotland
Great Britain
Europe
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1KJ
1OB
1OC
23N
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6J9
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8F7
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAKAS
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAYEP
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHEFC
AI.
AIACR
AIAGR
AIDQK
AIDYY
AIQQE
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EGARE
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IH2
IHE
IX1
J0M
J5H
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
V9Y
VH1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHHS
AAYXX
ACCFJ
ADZOD
AEEZP
AEQDE
AIWBW
AJBDE
CITATION
IQODW
24P
AEUQT
AFPWT
CGR
CUY
CVF
ECM
EIF
ESX
NPM
WRC
WUP
YIN
7X8
ID FETCH-LOGICAL-c5163-719c5d4abf2855adc4fcaceeb12ec1ddcba64af67e869c20d0514dd4455cd0c93
IEDL.DBID DR2
ISSN 0007-1048
IngestDate Fri Jul 11 03:00:02 EDT 2025
Wed Feb 19 02:35:50 EST 2025
Mon Jul 21 09:13:58 EDT 2025
Thu Apr 24 22:59:38 EDT 2025
Tue Jul 01 00:54:26 EDT 2025
Sun Sep 21 06:13:52 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Viscosity
Nervous system diseases
Stroke
Rheology
Cardiovascular disease
Coronary heart disease
Epidemiology
Blood
Cerebral disorder
Vascular disease
Central nervous system disease
Risk factor
Fibrinogen
Hematocrite
Coagulation factor
Cerebrovascular disease
Public health
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5163-719c5d4abf2855adc4fcaceeb12ec1ddcba64af67e869c20d0514dd4455cd0c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.1997.8532481.x
PMID 9012704
PQID 78815499
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_78815499
pubmed_primary_9012704
pascalfrancis_primary_2543511
crossref_primary_10_1046_j_1365_2141_1997_8532481_x
crossref_citationtrail_10_1046_j_1365_2141_1997_8532481_x
wiley_primary_10_1046_j_1365_2141_1997_8532481_x_BJH853
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate January 1997
1997-01-00
1997
1997-Jan
19970101
PublicationDateYYYYMMDD 1997-01-01
PublicationDate_xml – month: 01
  year: 1997
  text: January 1997
PublicationDecade 1990
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle British journal of haematology
PublicationTitleAlternate Br J Haematol
PublicationYear 1997
Publisher Blackwell Science Ltd
Blackwell
Publisher_xml – name: Blackwell Science Ltd
– name: Blackwell
SSID ssj0013051
Score 2.0840724
Snippet We examined the relationships of whole blood viscosity and its major determinants to incident cardiovascular events (ischaemic heart disease and stroke) in a...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 168
SubjectTerms Aged
Biological and medical sciences
Blood Viscosity
Cardiology. Vascular system
Cerebrovascular Disorders - blood
Cerebrovascular Disorders - etiology
Coronary heart disease
Female
fibrinogen
Fibrinogen - analysis
Follow-Up Studies
haematocrit
Heart
Humans
ischaemic heart disease
Male
Medical sciences
Middle Aged
Myocardial Ischemia - blood
Myocardial Ischemia - etiology
Risk Factors
stroke
Title Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study
URI https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1365-2141.1997.8532481.x
https://www.ncbi.nlm.nih.gov/pubmed/9012704
https://www.proquest.com/docview/78815499
Volume 96
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9tAEB5CDqUQmj4SqrRp99CrjLSe1aO35oUJuIfQQG7LPrQQ2sohtkvdX9-ZleTgJoe09CYhRkijWc0nzTffAHwo0MjK5TJFgtMplvSBYotAW05SPixMESz3Dk8_F5NLPL9SV317NPfCdPoQ6x9uvDLi-5oXuLHdFJIsqtsODK0cc265K0eUeCRW-YgRJR1iIf2TC3lXUshUPz6vpHcPVoMCKd6Rve6faiNb7dyYOTkudBMvHoKkmwg3pqizXfg-3FzHTPk6Wi7syP36Q_fxf939c3jWY1nxqQu-F7DVtC_hybSv1r-C6RGz4sWP67ljathKmNYL5rKLWRBugwgropDU_KMgPCpOKZ_G6g-furldCSY7rvbg8uz0y_Ek7cc3pE4RykvLvHbKo7FBVkoZ7zA4QznZ5rJxuffOGoqUUJRNVdROZp6l2L1HVMr5zNXjfdhuZ23zGoSsK4JSYwyELnBsVC29zywqGwiQVdIlUA-PSbte25xHbHzTscaO3I_G_tLsL83-0r2_9M8Exmvbm07h41FWhxvRsDZlcQECsQm8H6JD04LlKoxpm9lyrlm_nz_KE9jvgmZtWkcaACZQxif_F1ejj84ntHPwz5Zv4Gmny8v_lt7C9uJ22RwS2lrYd3EV_QaQhxgV
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5VRQIkxLsiQKkPXLNsvOM8uFHUailND6iVerP8iKUKlK26u1WXX8-Mk2y1wAEQt-QwUTyZ8XzxfP4M8DZHI0uXyRQJTqdY0A-KzQNdOUn1MDd5sLx3uD7Jp2d4dK7Ot6Ae9sJ0-hDrBTfOjDhfc4LzgvS7vi3ZZXmkaGWY8Z67YkSVR2KZjQhS3okNO8ZIX-RtU2Gs-gP0Cpp9sBw0SPGW7vXrszbq1YNLMyfXhe7Mi9-B0k2MG4vU4SNoh-F13JSvo-XCjtz3n5Qf_9v4H8PDHs6KD138PYGtpn0Kd-u-Yf8M6n0mxovri7ljdthKmNYLprOLWRBugwsropbU_L0gSCoOqKTGBhA_urlaCeY7rp7D2eHB6cdp2p_gkDpFQC8tssopj8YGWSplvMPgDJVlm8nGZd47ayhYQl40ZV45Ofasxu49olLOj1012YHtdtY2L0DIqiQ0NcFAAAMnRlXS-7FFZQNhslK6BKrhO2nXy5vzKRvfdGyzI29JY39p9pdmf-neX_omgcna9rIT-fgjq92NcFibsr4A4dgE9obw0JSz3IgxbTNbzjVL-PN_eQI7XdSsTavIBMAEivjp_-Jt9P7RlG5e_rPlHtybntbH-vjTyedXcL-T6eWlptewvbhaNrsEvhb2TUypHyd3HDM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB6hIlVIqOVV4T7oHrg6xJtZP7i10CgUUiFEpd5W-_BKFeBETYIIv56ZtZMqwAEQN_swlj074_ns-eZbgOc5Glm6TKZIcDrFgj5QbB7oyEmqh7nJg-XZ4fFFPrrE8yt11Y1H8yxMqw-x_uHGmRHf15zgUx9edF3JNskjQyvDjEfuih4VHoll1iNEeRdzqpsMkT7I255CX3X75xX08sFyJUGKt2yvX6-1Ua7uT82MPBfaLS9-h0k3IW6sUcNd-LJ6upaa8qm3mNue-_6T8OP_evwHsNOBWXHSRt9DuFM3j2B73LXrH8P4lGnx4uv1zDE3bClM4wWT2cUkCLfBhBVRSWr2UhAgFWdUUGP7hy9d3ywFsx2XT-ByePbx1Sjt9m9InSKYlxZZ5ZRHY4MslTLeYXCGirLNZO0y7501FCohL-oyr5zse9Zi9x5RKef7rhrswVYzaeqnIGRVEpYaYCB4gQOjKul936KygRBZKV0C1WqZtOvEzXmPjc86NtmRB9LYX5r9pdlfuvOX_pbAYG07bSU-_sjqaCMa1qasLkAoNoHjVXRoylhuw5imnixmmgX8-as8gb02aNamVeQBYAJFXPm_uBt9ej6ik_1_tjyG7fevh_rdm4u3B3Cv1ejl_0yHsDW_WdRHhLzm9llMqB-mahri
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood+viscosity+and+risk+of+cardiovascular+events+%3A+The+Edinburgh+Artery+Study&rft.jtitle=British+journal+of+haematology&rft.au=LOWE%2C+G.+D.+O&rft.au=LEE%2C+A.+J&rft.au=RUMLEY%2C+A&rft.au=PRICE%2C+J.+F&rft.date=1997&rft.pub=Blackwell&rft.issn=0007-1048&rft.volume=96&rft.issue=1&rft.spage=168&rft.epage=173&rft_id=info:doi/10.1046%2Fj.1365-2141.1997.8532481.x&rft.externalDBID=n%2Fa&rft.externalDocID=2543511
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1048&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1048&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1048&client=summon